ANGELA HARRIS: Open Payments
NPI 1144656935 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 52 payments from 24 companies in 2025. Trend: 2023 $982 · 2024 $1,064 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| Exact Sciences Corporation | 6 | $114 |
| ABBVIE INC. | 4 | $85 |
| Abbott Laboratories | 4 | $64 |
| Azurity Pharmaceuticals, Inc. | 3 | $58 |
| GENZYME CORPORATION | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Ethicon US, LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Lilly USA, LLC | 2 | $29 |
Products named: Cologuard Collection Kit, Rybelsus, FREESTYLE LIBRE 3, FABRAZYME, TRELEGY ELLIPTA, LINZESS, EDARBI, VRAYLAR.
Industry payments across MI — which companies pay providers there.
